by Tom Salemi
Founded in 1973, Johnson & Johnson Development Corp. (JJDC) is highly lauded by venture capitalists as perhaps the premier corporate venturing unit. It’s a prolific investor, usually among the most active investors in both biopharmaceutical and medical device start-ups. And it invests well, regularly finishing among the top tier of health-care investors ranked according to the number of portfolio companies that have gone public or been acquired
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?